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The American Journal of Pathology Centennial Project
The Centennial Celebration Is Over, But the Science
Moves Forward
Kevin A. RothFrom the Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama (Editor-in-Chief)The American Journal of Pathology Centennial Project has
commemorated the 100th anniversary of the founding of the
American Society for Experimental Pathology (ASEP) and its
afﬁliation with the Federation of American Societies for
Experimental Biology (FASEB) by publishing a series of
monthly articles throughout the past year. The AJP is the
ofﬁcial journal of the American Society for Investigative
Pathology (ASIP),which traces its roots to themerger ofASEP
and the American Association of Pathologists and Bacteriol-
ogists (AAPB) in 1976. The AJP Centennial Project has
included editorials, perspectives, commentaries, and reviews
that spotlight advances in investigative pathology research
published in the AJP and its predecessor journals, the Journal
of the Boston Society of Medical Sciences and The Journal of
Medical Research. These articles have been educational,
enlightening, and sometimes entertaining, and I hope that you
have enjoyed reading them as much as I have. Publication of
this closingAJPCentennial Project Editorial coincideswith the
ASEP Centennial Celebration at the ASIP 2013 Annual
Meeting on Experimental Biology in Boston, MA, and marks
the start of a new century of experimental pathology research.
In my April 2012 editorial announcing the AJP Centennial
Project,1 I had the relatively easy task of outlining the history
of ASEP, AAPB, their merger into the American Association
of Pathologists (AAP), and the re-incorporation in 1992 as
ASIP. Similarly, I described the evolution of the AJP from its
predecessor journals and provided my reﬂections on the
history of these esteemed journals. In this concluding editorial,
I have themuchmore difﬁcult task of speculating on the future
of investigative pathology rather than simply reporting on its
past. My task was recently made somewhat easier, however,
when in December 2012, the New England Journal of Medi-
cine (NEJM ) published a brief editorial entitled “AGlimpse of
the Next 100 Years in Medicine” to mark the conclusion of its
200th year of publication.2 Given NEJM’s additional 100Copyright ª 2013 American Society for Investigative Pathology.
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http://dx.doi.org/10.1016/j.ajpath.2013.02.001years of experience and my admiration of all things Boston
(including the Institute of Contemporary Art, site of the ASIP
2013 Centennial Reception and Dinner), I will echo some of
the points made in that editorial and provide my pathological
perspective on the future of our scientiﬁc discipline.
Most importantly to both medicine and pathology, “the
pace of biomedical discovery will accelerate.”2,p2538 New
metabolomic, proteomic, genomic, and epigenetic testing on
human specimens combined with detailed electronic health
records will revolutionize both clinical practice (precision
medicine) and investigative pathology. The boundaries
between basic research and medical practice will be blurred,
and frequently, mechanistic insights and new hypotheses will
be generated from clinically acquired data. Massive data sets
derived from genetic testing and large patient populations, (ie,
big data) will require new approaches to informatics and force
us to confront difﬁcult privacy and medicological issues
regarding data sharing and informed consent. For both diag-
nostic anatomic pathology and a large portion of investigative
pathology that relies on microscopic examination of cells and
tissues, new imaging and analytical tools will become integral
parts of our professional lives.3,4 However, this future will
present us with some, perhaps, unexpected and surprising
results that will challenge our very identity as pathologists and
scientists. For example, a recent publication in Lab Chip re-
ported the results of an interesting study on BioGames.5 The
authors reported that the combined diagnostic accuracy of
approximately 1000 untrained individuals located in more
than 60 countries looking at digital microscopic images of
uninfected and malaria-infected red blood cells on personal
computers, tablets, andmobile phoneswas equivalent to that of
expert medical professionals. I ﬁnd this report both scary (for
diagnostic pathologists) and inspirational. I seriously doubt that
pathologists will lose their clinical relevance in the future, and
indeed, the discipline has embraced change in advocating for
ASIP Centennial Editorialnext-generation, personalized, and third-track pathology.6e8
Integration of big data into investigative pathology research
is also occurring rapidly, and it is just a matter of time before
informatics training is a required element of graduate and
postgraduate education in pathology research.
As we move proudly into ASIP’s second century of
scientiﬁc discovery, this is an exciting time to be an investi-
gative pathologist. We should be honored and humbled to
build on the scientiﬁc foundation laid by our predecessors in
ASEP. With the help of ASIP’s members, including its
trainees, we will redeﬁne our discipline in the new era of
pathology, informatics, and genomics.
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